These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37652682)

  • 1. Increased viral load in patients infected with severe acute respiratory syndrome coronavirus 2 Omicron variant in the Republic of Korea.
    Kim JM; Kim D; Lee NJ; Woo SH; Lee J; Lee H; Park AK; Kim JA; Lee CY; Kim IH; Yoo CK; Kim EJ
    Osong Public Health Res Perspect; 2023 Aug; 14(4):272-278. PubMed ID: 37652682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in Viral Load in Patients With SARS-CoV-2 Delta Variant Infection in the Republic of Korea.
    Kim JM; Rhee JE; Yoo M; Kim HM; Lee NJ; Woo SH; Jo HJ; Kwon D; Lee S; Yoo CK; Kim EJ
    Front Microbiol; 2022; 13():819745. PubMed ID: 35308391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Sensitivity of Saliva and Other Respiratory Tract Samples of SARS-CoV-2 Variants in Patients with COVID-19.
    Lawrence Panchali MJ; Kim CM; Lee YM; Seo JW; Kim DY; Yun NR; Kim DM
    Microbiol Spectr; 2023 Mar; 11(2):e0307622. PubMed ID: 36976007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Omicron variant BA.1.1 presents a lower pathogenicity than B.1 D614G and Delta variants in a feline model of SARS-CoV-2 infection.
    Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG
    bioRxiv; 2022 Jun; ():. PubMed ID: 35734088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA loads of severe acute respiratory syndrome coronavirus 2 in patients with breakthrough coronavirus disease 2019 caused by the Delta and Omicron variants.
    de Michelena P; Torres I; Ferrando EC; Olea B; González-Candelas F; Sánchez G; Navarro D
    Clin Microbiol Infect; 2023 Feb; 29(2):256.e1-256.e4. PubMed ID: 36115649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of epidemiological characteristics and transmissibility of different strains of COVID-19 based on the incidence data of all local outbreaks in China as of March 1, 2022.
    Niu Y; Luo L; Yang S; Abudurusuli G; Wang X; Zhao Z; Rui J; Li Z; Deng B; Liu W; Zhang Z; Li K; Liu C; Li P; Huang J; Yang T; Wang Y; Chen T; Li Q
    Front Public Health; 2022; 10():949594. PubMed ID: 36187650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?
    Duong BV; Larpruenrudee P; Fang T; Hossain SI; Saha SC; Gu Y; Islam MS
    Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Airborne virus shedding of the alpha, delta, omicron SARS-CoV-2 variants and influenza virus in hospitalized patients.
    Ong DSY; de Man P; Verhagen T; Doejaaren G; Dallinga MA; Alibux E; Janssen ML; Wils EJ
    J Med Virol; 2023 Apr; 95(4):e28748. PubMed ID: 37185846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Omicron Mutation Is Faster than the Chase: Multiple Mutations on Spike/ACE2 Interaction Residues.
    Kim S; Nguyen TT; Taitt AS; Jhun H; Park HY; Kim SH; Kim YG; Song EY; Lee Y; Yum H; Shin KC; Choi YK; Song CS; Yeom SC; Kim B; Netea M; Kim S
    Immune Netw; 2021 Dec; 21(6):e38. PubMed ID: 35036025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Omicron Variant, Lineage BA.1, Is Associated with Lower Viral Load in Nasopharyngeal Samples Compared to Delta Variant.
    Sentis C; Billaud G; Bal A; Frobert E; Bouscambert M; Destras G; Josset L; Lina B; Morfin F; Gaymard A; The Covid-Diagnosis Hcl Study Group
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.
    Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G
    J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic epidemiology of SARS- CoV-2 Omicron variants in the Republic of Korea.
    Lee DW; Kim JM; Park AK; Kim DW; Kim JY; Lim N; Lee H; Kim IH; Kim JA; Lee CY; Kwon JH; Kim EJ
    Sci Rep; 2022 Dec; 12(1):22414. PubMed ID: 36575217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and computational analysis of spike protein of newly emerged omicron variant in comparison to the delta variant of SARS-CoV-2 in Iraq.
    Rashid PMA; Salih GF
    Mol Biol Rep; 2022 Aug; 49(8):7437-7445. PubMed ID: 35698014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral load of SARS-CoV-2 Omicron is not high despite its high infectivity.
    Yuasa S; Nakajima J; Takatsuki Y; Takahashi Y; Tani-Sassa C; Iwasaki Y; Nagano K; Sonobe K; Yoshimoto T; Nukui Y; Takeuchi H; Tanimoto K; Tanaka Y; Kimura A; Ichimura N; Tohda S
    J Med Virol; 2022 Nov; 94(11):5543-5546. PubMed ID: 35790476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The "vaccine" hubbub: Viral load comparisons of SARS-CoV-2 Delta and Omicron variants against different vaccine-booster vaccine combinations.
    Ergoren MC; Akan G; Volkan E; Kandemis E; Evren EU; Evren H; Volkan E; Tuncel G; Suer K; Sanlidag T
    J Med Virol; 2023 Jan; 95(1):e28309. PubMed ID: 36377303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy and in vitro neutralization capacity of monoclonal antibodies for severe acute respiratory syndrome coronavirus 2 delta and omicron variants.
    Brehm TT; Pfefferle S; von Possel R; Karolyi M; Zoufaly A; Wichmann D; Kobbe R; Emmerich P; Nörz D; Aepfelbacher M; Schulze Zur Wiesch J; Addo MM; Schmiedel S; Lütgehetmann M
    J Med Virol; 2022 Oct; 94(10):5038-5043. PubMed ID: 35662058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
    Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
    PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants.
    Gellenoncourt S; Saunders N; Robinot R; Auguste L; Rajah MM; Kervevan J; Jeger-Madiot R; Staropoli I; Planchais C; Mouquet H; Buchrieser J; Schwartz O; Chakrabarti LA
    J Virol; 2022 Oct; 96(19):e0130122. PubMed ID: 36121299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
    Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L
    J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.